173 related articles for article (PubMed ID: 29184052)
21. Rheb may complex with RASSF1A to coordinate Hippo and TOR signaling.
Nelson N; Clark GJ
Oncotarget; 2016 Jun; 7(23):33821-31. PubMed ID: 27034171
[TBL] [Abstract][Full Text] [Related]
22. Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity.
Finlay GA; Malhowski AJ; Liu Y; Fanburg BL; Kwiatkowski DJ; Toksoz D
Cancer Res; 2007 Oct; 67(20):9878-86. PubMed ID: 17942919
[TBL] [Abstract][Full Text] [Related]
23. Metastasis of benign tumor cells in tuberous sclerosis complex.
Henske EP
Genes Chromosomes Cancer; 2003 Dec; 38(4):376-81. PubMed ID: 14566858
[TBL] [Abstract][Full Text] [Related]
24. Anti-EGFR antibody efficiently and specifically inhibits human TSC2-/- smooth muscle cell proliferation. Possible treatment options for TSC and LAM.
Lesma E; Grande V; Ancona S; Carelli S; Di Giulio AM; Gorio A
PLoS One; 2008; 3(10):e3558. PubMed ID: 18958173
[TBL] [Abstract][Full Text] [Related]
25. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.
Astrinidis A; Henske EP
Oncogene; 2005 Nov; 24(50):7475-81. PubMed ID: 16288294
[TBL] [Abstract][Full Text] [Related]
26. Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: epidermal growth factor is the required growth factor.
Lesma E; Grande V; Carelli S; Brancaccio D; Canevini MP; Alfano RM; Coggi G; Di Giulio AM; Gorio A
Am J Pathol; 2005 Oct; 167(4):1093-103. PubMed ID: 16192644
[TBL] [Abstract][Full Text] [Related]
27. Distinct roles of Rheb and Raptor in activating mTOR complex 1 for the self-renewal of hematopoietic stem cells.
Peng H; Kasada A; Ueno M; Hoshii T; Tadokoro Y; Nomura N; Ito C; Takase Y; Vu HT; Kobayashi M; Xiao B; Worley PF; Hirao A
Biochem Biophys Res Commun; 2018 Jan; 495(1):1129-1135. PubMed ID: 29175333
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary lymphangioleiomyomatosis in a man.
Aubry MC; Myers JL; Ryu JH; Henske EP; Logginidou H; Jalal SM; Tazelaar HD
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):749-52. PubMed ID: 10934115
[TBL] [Abstract][Full Text] [Related]
29. Dissociate expression of tuberous sclerosis complex 1 product hamartin in a skin and pulmonary lesion of a tuberous sclerosis complex.
Wataya-Kaneda M; Katayama I
Hum Pathol; 2009 Mar; 40(3):430-4. PubMed ID: 18835623
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex.
Schiavina M; Di Scioscio V; Contini P; Cavazza A; Fabiani A; Barberis M; Bini A; Altimari A; Cooke RM; Grigioni WF; D'Errico-Grigioni A
Am J Respir Crit Care Med; 2007 Jul; 176(1):96-8. PubMed ID: 17431222
[TBL] [Abstract][Full Text] [Related]
31. Rheb activates AMPK and reduces p27Kip1 levels in Tsc2-null cells via mTORC1-independent mechanisms: implications for cell proliferation and tumorigenesis.
Lacher MD; Pincheira R; Zhu Z; Camoretti-Mercado B; Matli M; Warren RS; Castro AF
Oncogene; 2010 Dec; 29(50):6543-56. PubMed ID: 20818424
[TBL] [Abstract][Full Text] [Related]
32. Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies.
Shah OJ; Wang Z; Hunter T
Curr Biol; 2004 Sep; 14(18):1650-6. PubMed ID: 15380067
[TBL] [Abstract][Full Text] [Related]
33. Incidental Pelvic and Para-aortic Lymph Node Lymphangioleiomyomatosis Detected During Surgical Staging of Pelvic Cancer in Women Without Symptomatic Pulmonary Lymphangioleiomyomatosis or Tuberous Sclerosis Complex.
Rabban JT; Firetag B; Sangoi AR; Post MD; Zaloudek CJ
Am J Surg Pathol; 2015 Aug; 39(8):1015-25. PubMed ID: 25786086
[TBL] [Abstract][Full Text] [Related]
34. Angiomyolipoma of kidney.
Eble JN
Semin Diagn Pathol; 1998 Feb; 15(1):21-40. PubMed ID: 9503504
[TBL] [Abstract][Full Text] [Related]
35. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms.
Kenerson H; Folpe AL; Takayama TK; Yeung RS
Hum Pathol; 2007 Sep; 38(9):1361-71. PubMed ID: 17521703
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary lymphangioleiomyomatosis in tuberous sclerosis. A case report.
De Rosa N
Pathologica; 2009 Oct; 101(5):186-9. PubMed ID: 20218060
[TBL] [Abstract][Full Text] [Related]
37. A patient with TSC1 germline mutation whose clinical phenotype was limited to lymphangioleiomyomatosis.
Sato T; Seyama K; Kumasaka T; Fujii H; Setoguchi Y; Shirai T; Tomino Y; Hino O; Fukuchi Y
J Intern Med; 2004 Aug; 256(2):166-73. PubMed ID: 15257730
[TBL] [Abstract][Full Text] [Related]
38. Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis.
Yu J; Astrinidis A; Henske EP
Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1537-40. PubMed ID: 11704609
[TBL] [Abstract][Full Text] [Related]
39. Human Pluripotent Stem Cell-Derived
Julian LM; Delaney SP; Wang Y; Goldberg AA; Doré C; Yockell-Lelièvre J; Tam RY; Giannikou K; McMurray F; Shoichet MS; Harper ME; Henske EP; Kwiatkowski DJ; Darling TN; Moss J; Kristof AS; Stanford WL
Cancer Res; 2017 Oct; 77(20):5491-5502. PubMed ID: 28830860
[TBL] [Abstract][Full Text] [Related]
40. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.
Sato T; Seyama K; Fujii H; Maruyama H; Setoguchi Y; Iwakami S; Fukuchi Y; Hino O
J Hum Genet; 2002; 47(1):20-8. PubMed ID: 11829138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
